ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.7371
0.12%
Brent Oil
80.505
-0.14%
Bitcoin
94,087.37
-0.43%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRB)

  7. Cellectar Biosciences Inc (CLRB) Noticias

CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLRB
FechaHoraFuenteTítuloSímboloCompañía
12/01/202517:00GlobeNewswire Inc.Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare ConferenceNASDAQ:CLRBCellectar Biosciences Inc
11/12/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
10/12/202416:00GlobeNewswire Inc.Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate RestructuringNASDAQ:CLRBCellectar Biosciences Inc
18/11/202406:05GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
18/11/202405:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202415:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202415:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
14/11/202407:05GlobeNewswire Inc.Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225NASDAQ:CLRBCellectar Biosciences Inc
13/11/202415:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
12/11/202407:05GlobeNewswire Inc.Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of CancerNASDAQ:CLRBCellectar Biosciences Inc
11/11/202415:05GlobeNewswire Inc.Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024NASDAQ:CLRBCellectar Biosciences Inc
07/11/202405:40GlobeNewswire Inc.Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024NASDAQ:CLRBCellectar Biosciences Inc
01/11/202416:00GlobeNewswire Inc.Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-QNASDAQ:CLRBCellectar Biosciences Inc
29/10/202416:03Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
29/10/202415:56Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
26/08/202405:40GlobeNewswire Inc.Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
23/08/202416:00GlobeNewswire Inc.Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from NasdaqNASDAQ:CLRBCellectar Biosciences Inc
13/08/202405:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
08/08/202416:15GlobeNewswire Inc.UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
08/08/202415:05GlobeNewswire Inc.Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
23/07/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CLRBCellectar Biosciences Inc
23/07/202405:40GlobeNewswire Inc.Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 MonthsNASDAQ:CLRBCellectar Biosciences Inc
22/07/202405:40GlobeNewswire Inc.Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 MillionNASDAQ:CLRBCellectar Biosciences Inc
27/06/202405:40GlobeNewswire Inc.Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market LandscapeNASDAQ:CLRBCellectar Biosciences Inc
18/06/202416:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLRBCellectar Biosciences Inc
29/05/202405:40GlobeNewswire Inc.Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis FungoidesNASDAQ:CLRBCellectar Biosciences Inc
24/05/202415:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CLRBCellectar Biosciences Inc
16/05/202405:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:CLRBCellectar Biosciences Inc
14/05/202405:40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
08/05/202405:40GlobeNewswire Inc.Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals DayNASDAQ:CLRBCellectar Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLRB

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
COIN
ADAUSD
Cardano
FX
USDMXN
US Dollar vs MXN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados